What is Monopar Therapeutics's total current liabilities?

Monopar Therapeutics (MNPR) reported total current liabilities of $2.46M in Q1 2026.

What is the long-term trend for Monopar Therapeutics's total current liabilities?

Over 5 years (2020 to 2025), Monopar Therapeutics's total current liabilities has grown at a 18.4% compound annual growth rate (CAGR), from $1.18M to $2.74M.

What does total current liabilities mean?

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Monopar Therapeutics MNPR Total Current Liabilities

Total Current Liabilities at other companies

Bristol-Myers SquibbBMY

$19.16B-20.4%

Eli LillyLLY

$36.63B+21.8%

Bausch Health CompaniesBHC

$4.53B+6.4%

Ultragenyx PharmaceuticalRARE

$325M+11.4%

Prime MedicinePRME

$36.29M+5.8%

Wave Life SciencesWVE

$49.83M-43.0%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's total current liabilities?: Monopar Therapeutics (MNPR) reported total current liabilities of $2.46M in Q1 2026.
What is the long-term trend for Monopar Therapeutics's total current liabilities?: Over 5 years (2020 to 2025), Monopar Therapeutics's total current liabilities has grown at a 18.4% compound annual growth rate (CAGR), from $1.18M to $2.74M.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.